home / stock / achv / achv news


ACHV News and Press, Achieve Life Sciences Inc. From 09/28/18

Stock Information

Company Name: Achieve Life Sciences Inc.
Stock Symbol: ACHV
Market: NASDAQ
Website: achievelifesciences.com

Menu

ACHV ACHV Quote ACHV Short ACHV News ACHV Articles ACHV Message Board
Get ACHV Alerts

News, Short Squeeze, Breakout and More Instantly...

ACHV - Today's Research Reports on Stocks to Watch: Achieve Life Sciences and Acasti Pharma

NEW YORK, NY / ACCESSWIRE / September 28, 2018 / Shares of biotech stocks Achieve Life Sciences and Acasti Pharma were both seeing big gains in Thursday's session. It was positive study results for Achieve that sent shares flying while Acasti moved on no news. RDI Initiates Coverage on: ...

ACHV - Midday Gainers / Losers (09/27/2018)

Gainers:  ACHV +58% . RXII +36% . IGC +26% . GBR +25% . HAIR +20% . YGYI +18% . NTGN +17% . LQDA +16% . ARAY +17% . CCJ +16% . More news on: Achieve Life Sciences, Inc., RXI Pharmaceuticals Corporation, India Globalization Capital, Inc, Stocks on the mo...

ACHV - Premarket Gainers as of 9:05 am (09/27/2018)

ACHV +35%  on performance of new cytisine formulation. More news on: Achieve Life Sciences, Inc., Cameco Corporation, India Globalization Capital, Inc, Stocks on the move, Top stock market news, , Read more ...

ACHV - Achieve Life Sciences up 38% premarket on performance of new cytisine formulation

Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up  38%  premarket on increased volume in response to its announcement that a new formulation of smoking cessation candidate cytisine demonstrated bioequivalence in healthy volunteer smokers with or without food. The results were ...

ACHV - Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects

SEATTLE and VANCOUVER, British Columbia , Sept. 27, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced results of a clini...

ACHV - Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018

SEATTLE and VANCOUVER, British Columbia , Sept. 26, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that Rick Stewa...

Previous 10 Next 10